Skip to main content
Sign In

Genevieve Moyer, MD

Genevieve Moyer, MD
University of Colorado School of Medicine
  • Hematology/Oncology Fellow​
  • Clinical Instructor

Contact information

13199 East Montview Blvd, Suite 100
Hemostasis and Thrombosis Center, Mailstop F416
Aurora, CO  80045

Genevieve (Jenna) Moyer is completing her hematology/oncology fellowship here at University of Colorado and will be starting as a Clinical Instructor July 2018.  Prior to starting her fellowship in 2015, she completed medical school and Internal Medicine/Chief Residencies at Saint Louis University. 

Dr. Moyer is a recipient of the 2018 Hemostasis and Thrombosis Research Society / Novo Nordisk Clinical Fellowship in Rare Bleeding Disorders. She is one of two applicants to be chosen for this fellowship award, which will provide support for her to receive clinical training at the University of Colorado Hemophilia and Thrombosis Center. She will work with her mentors Dr. Tyler Buckner and Dr. Marilyn Manco-Johnson during the award. In addition to obtaining training and experience caring for individuals with bleeding disorders, Dr. Moyer will lead a project focused on improving the care we provide to women with bleeding disorders.  She will also continue her research which is currently aimed at identifying biomarkers to risk stratify patients who require anticoagulation yet have an underlying risk of bleeding. 

  • Arizona State University, BS, Kinesiology, 2007
  • Saint Louis University School of Medicine, MD, 2011
  • Saint Louis University School of Medicine​, Residency, 2011-2015
  • University of Colorado Anschutz Medical​, Hematology/Oncology Fellowship, 2015-2018 
  • University of Colorado Anschutz Medical, MS, Clinical Science, expected 2019

​At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research aimed at bridging knowledge gaps in the area of cancer associated thrombosis.  The University of Colorado is a large malignant hematology treatment center and performs among the most umbilical cord blood stem cell transplants in the world.  My first research question focused around the VTE incidence in individuals who underwent stem cell transplant from different stem cell donor sources. I conducted a retrospective chart review on VTE characteristics in individuals from our institution after allogeneic HSCT, focusing on differences between cord blood and non-cord blood recipients.  I discovered that not only was post-transplant VTE a serious problem in all individuals who undergo allogeneic stem cell transplant regardless of donor source, but also that these patients were at an extremely high risk of bleeding with anticoagulation.  As a result of this endeavor, I have developed an interest in pursuing a career aimed at developing tools to risk stratify complex patients who develop VTE in the setting of a high risk of bleeding such as during thrombocytopenia.  This has led me to my current project, aimed at prospectively evaluating clinical and laboratory variables which have been shown to be predictive of post-transplant VTE in retrospective studies, as well as the use of thromboelastography (TEG) to predict bleeding and re-thrombosis in these patients.   

  • Moyer GC, Grubb RL, Johnson FE. Intestinal adenocarcinoma arising in urinary conduits.  Oncol Rep. 2012 Feb; 27(2): 371-5.

  • Gastrointestinal cancers arising in urinary tract conduits. 89-T. Proceedings of the 34th Annual Meeting of the American Society of Preventative Oncology.  March 21-23, 2010. Bethesda, MD.   Poster Presentation 

  • Gastrointestinal adenocarcinomas developing in isolated intestinal segments used for urinary diversion.  Abstract 80.  Journal of Cancer Education special section associated with the International Cancer Education Conference, 2010. Oral Presentation

  • Internal Medicine in Review.  Study Guide. Oncology Chapter.  Ertel, Normal H. Sanovaworks. 2012.  Print

  • Internal Medicine in Review. Exam Cram Pack.  Oncology Chapter. Paniagua, Miguel A. Sanovaworks. 2013. Print

  • Clostridium Difficile Prophylaxis in Oncology Patients with Diarrhea.  2012 Regional American College of Physicians meeting.  Poster Presentation

  • Paraneoplastic Cardiomyopathy treated with Doxycycline.  2013 Regional American College of Physician’s meeting.  Poster Presentation